葡萄糖类1及其同类与粉样β之间的相互作用会影响其动和细胞毒性
Ekaterina A Litus1, Marina P Shevelyova1, Alisa A Vologzhannikova1
1Institute for Biological Instrumentation, Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences, 142290 Pushchino, Russia.
International journal of molecular sciences
|May 14, 2025
概括
类似葡萄糖类1受体激动剂 (GLP-1RAs) 直接与粉样β (Aβ) 相互作用,调节Aββ.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 抗糖尿病药物,特别是GLP-1RAs,通过影响粉样β (Aβ) 代谢,在阿尔茨海默病 (AD) 中表现出治疗潜力.
- GLP-1RAs和Aβ之间的直接相互作用及其功能结果尚不清楚.
研究的目的:
- 调查GLP-1(7-37) 与其类型 (塞马格卢提德,利拉格卢提德,埃克塞纳提德) 和单体Aβ40/Aβ42.2之间的直接结合相互作用.
- 探索这些相互作用对Aβ纤维化和细胞毒性的功能后果.
主要方法:
- 生物层干涉测量和表面等离子体共振光谱学被用来研究分子相互作用.
- 动态光散射评估了GLP-1RAs的四级结构.
- 提奥夫拉T检测,电子显微镜和MTT检测评估了Aβ纤维化和细胞毒性.
主要成果:
- 观察到GLP-1 ((7-37) 与单体Aβ40和Aβ42之间的直接结合,其中liraglutide表现出最高的亲和力.
- GLP-1RAs表现出寡合化趋势.
- GLP-1 ((7-37) 和埃克萨纳提德抑制了Aβ40纤维化; 半氨酸促进了它.
- GLP-1类似物降低了Aβ细胞毒性,但GLP-1(7-37) 增加了Aβ40细胞毒性.
结论:
- GLP-1RAs直接与Aβ结合.
- 这些相互作用对Aβ纤维化和细胞毒性有不同的影响,表明复杂的调节作用.
- 进一步的体内研究是有必要的,以在阿尔茨海默病的背景下探索这些观察到的效应.
相关概念视频
Glucagon-like Receptor Agonists
276
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
276
Amyloid Fibrils
9.1K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.1K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.0K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.0K
Hypoglycemia and Glucagon
143
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
143
Dipeptidyl Peptidase 4 Inhibitors
142
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
142
Insulin Secretory Vesicles
4.8K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
4.8K


